There is accumulating evidence in the literature indicating that a number of patients with
coronavirus disease 2019 (COVID‑19) may experience a range of neuropsychiatric …

Recent studies indicate that COVID-19 infection can lead to serious neurological
consequences in a small percentage of individuals. However, in the months following acute …

Background Neurological symptoms such as cognitive decline and depression contribute
substantially to post-COVID-19 syndrome, defined as lasting symptoms several weeks after …

Abstract Survivors of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
infection frequently experience lingering neurological symptoms, including impairment in …

Background Pregnant women are at increased risk for severe outcomes from coronavirus
disease 2019 (COVID-19), but the pathophysiology underlying this increased morbidity and …

Neurological manifestations are a significant complication of coronavirus disease (COVID-
19), but underlying mechanisms aren't well understood. The development of animal models …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …

Apolipoprotein E ε4 allele (APOE4) has been shown to associate with increased
susceptibility to SARS-CoV-2 infection and COVID-19 mortality in some previous genetic …

Abstract As coronavirus disease 2019 (COVID-19) and aging are both accompanied by
cognitive decline, we hypothesized that COVID-19 might lead to molecular signatures …

Objective To explore the lived experience of 'brain fog'—the wide variety of neurocognitive
symptoms that can follow COVID-19. Design and setting A UK-wide longitudinal qualitative …